Pitt–Hopkins syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Pitt–Hopkins syndrome
Image of a child with Pitt–Hopkins syndrome
Synonyms	PTHS
Pronounce
Specialty	Medical genetics
Symptoms	Developmental delay, intellectual disability, breathing abnormalities, seizures, distinctive facial features
Complications	N/A
Onset	Infancy
Duration	Lifelong
Types	N/A
Causes	Genetic mutation in the TCF4 gene
Risks
Diagnosis	Genetic testing
Differential diagnosis	Angelman syndrome, Rett syndrome, Mowat–Wilson syndrome
Prevention	N/A
Treatment	Symptomatic treatment, supportive care
Medication	Anticonvulsants for seizures
Prognosis	Variable, generally stable
Frequency	Rare, estimated 1 in 34,000 to 1 in 41,000
Deaths

Pitt–Hopkins syndrome (PTHS) is a rare genetic disorder characterized by developmental delay, intellectual disability, distinctive facial features, and breathing abnormalities. It is caused by mutations in the TCF4 gene, which plays a crucial role in the development and function of the nervous system.

Signs and Symptoms

Individuals with Pitt–Hopkins syndrome typically exhibit a range of symptoms, including:

• Severe intellectual disability
• Developmental delay
• Distinctive facial features such as a wide mouth, prominent lips, and deep-set eyes
• Breathing abnormalities, including episodes of hyperventilation and apnea
• Seizures
• Gastrointestinal issues, such as constipation
• Motor skills impairment
• Behavioral issues, including anxiety and stereotypic movements

Genetics

Pitt–Hopkins syndrome is caused by mutations in the TCF4 gene located on chromosome 18. The TCF4 gene is responsible for encoding a transcription factor that is essential for the development of the nervous system. Mutations in this gene disrupt normal brain development and function, leading to the symptoms observed in PTHS.

Diagnosis

Diagnosis of Pitt–Hopkins syndrome is based on clinical evaluation and genetic testing. The presence of characteristic facial features, developmental delay, and breathing abnormalities may prompt genetic testing to identify mutations in the TCF4 gene.

Management

There is currently no cure for Pitt–Hopkins syndrome. Management focuses on addressing the symptoms and improving the quality of life for affected individuals. This may include:

• Physical therapy and occupational therapy to improve motor skills
• Speech therapy to address communication difficulties
• Medications to manage seizures and behavioral issues
• Regular monitoring and treatment of gastrointestinal issues

Epidemiology

Pitt–Hopkins syndrome is a rare condition, with an estimated prevalence of less than 1 in 34,000 individuals. It affects both males and females equally.

History

Pitt–Hopkins syndrome was first described in 1978 by Dr. David Pitt and Dr. Ian Hopkins, who identified two patients with similar clinical features. Since then, advances in genetic testing have allowed for the identification of the underlying genetic cause of the syndrome.

See Also

• Intellectual disability
• Developmental delay
• Genetic disorders
• Seizures
• Physical therapy
• Occupational therapy
• Speech therapy